EXHIBIT 99.1

ATHEROGENICS, INC.

(Debtor-in-Possession)

BALANCE SHEET

April 30, 2009

(Unaudited)

Assets
Current assets:
	Cash and cash equivalents		$ 46,747,668
	Prepaid expenses		160,700
	Interest receivable and other current assets		13,947
		Total current assets	46,922,315
Equipment and leasehold improvements, net of accumulated depreciation
	and amortization		—
		Total assets	$ 46,922,315
Liabilities and Shareholders' Deficit
Current liabilities:
	Accounts payable		$          1,763
	Accrued professional fees		278,686
	Accrued and other liabilities		12,163
		Total current liabilities not subject to compromise	292,612
Prepetition liabilities			306,890,836
Shareholders' deficit
	Common stock		219,855,598
	Warrants		598,173
	Accumulated deficit		(480,714,904	)
		Total shareholders' deficit	(260,261,133	)
		Total liabilities and shareholders' deficit	$ 46,922,315

ATHEROGENICS, INC.

(Debtor-in-Possession)

STATEMENT OF OPERATIONS

For the month ended April 30, 2009

(Unaudited)

Revenues	$           —
Operating expenses:
Research and development	164,493
General and administrative	1,276,867
Total operating expenses	1,441,360
Operating loss	(1,441,360	)
Other income, net	1,328,065
Net loss before reorganization items	(113,295	)
Reorganization items, net	(378,557	)
Net loss	$ (491,852	)
Net loss per share –
basic and diluted	$       (0.01	)
Weighted average shares
outstanding – basic and diluted	39,518,492